Vilya

Vilya is a cutting-edge computational biotechnology company, co-founded by a team of scientists from from the Institute of Protein Design (IPD) led by David Baker, Ph.D. and by ARCH Venture Partners.

At Vilya, we are creating a novel class of medicines to precisely target disease biology. Our platform is built on ground-breaking research in advanced computational approaches and taps into uncharted chemical space within cyclic peptides to design new molecular structures not found in nature.

We aim to boldly leverage cutting edge computing to change how we design new medicines, and to ultimately cure diseases.

We are a group of machine learning scientists, computational chemists, medicinal chemists, biologists and scientific enthusiasts that are driven to design and create life-altering medicines that will make a big impact on the world. Learn more about our job openings and join us!